American Journal of Medical Genetics Part C (Seminars in Medical Genetics) 175C:70–115 (2017) RESEARCH REVIEW
The Ehlers–Danlos Syndromes, Rare Types ANGELA F. BRADY, SERWET DEMIRDAS, SYLVIE FOURNEL-GIGLEUX, NEETI GHALI, CECILIA GIUNTA, INES KAPFERER-SEEBACHER, TOMOKI KOSHO, ROBERTO MENDOZA-LONDONO, MICHAEL F. POPE, MARIANNE ROHRBACH, TIM VAN DAMME, ANTHONY VANDERSTEEN, CAROLINE VAN MOURIK, NICOL VOERMANS, JOHANNES ZSCHOCKE, AND FRANSISKA MALFAIT *
Dr. Angela F. Brady, F.R.C.P., Ph.D., is a Consultant Clinical Geneticist at the North West Thames Regional Genetics Service, London and she has a specialist interest in Ehlers–Danlos Syndrome. She was involved in setting up the UK National EDS Diagnostic Service which was established in 2009 and she has been working in the London part of the service since 2015. Dr. Serwet Demirdas, M.D., Ph.D., is a clinical geneticist in training at the Erasmus Medical Center (Erasmus University in Rotterdam, the Netherlands), where she is involved in the clinical service and research into the TNX deficient type of EDS. Prof. Sylvie Fournel-Gigleux, Pharm.D., Ph.D., is a basic researcher in biochemistry/pharmacology, Research Director at INSERM (Institut National de la Sante et de la Recherche Medicale) and co-head of the MolCelTEG Research Team at UMR 7561 CNRS-Universite de Lorraine. Her group is dedicated to the pathobiology of connective tissue disorders, in particular the Ehlers–Danlos syndromes, and specializes on the molecular and structural basis of glycosaminoglycan synthesis enzyme defects. Dr. Neeti Ghali, M.R.C.P.C.H., M.D., is a Consultant Clinical Geneticist at the North West Thames Regional Genetics Service, London and she has a specialist interest in Ehlers–Danlos Syndrome. She has been working in the London part of the UK National EDS Diagnostic Service since 2011. Dr. Cecilia Giunta, Ph.D., is a molecular geneticist and established scientist working in the field of Ehlers–Danlos Syndrome and other heritable connective tissue disorders (CTD) since 1995. Together with Dr. Marianne Rohrbach she runs the diagnostic and research activities of the Connective Tissue Unit as part of the Division of Metabolism at the University Children's Hospital, Zurich since September 2008. Her research focuses on the understanding of the Molecular Basis and Pathology of Connective Tissue Disorders, in particular the rare forms of EDS and osteogenesis imperfecta. She is currently a member of the medical and scientific board of the Ehlers–Danlos Society. Dr. Ines Kapferer-Seebacher, D.M.D., is a periodontist with a clinical and research focus on dental and periodontal manifestations of rare diseases. She is an Associate Professor at the Department of Restorative and Operative Dentistry, Medical University Innsbruck, Austria. Dr. Tomoki Kosho, M.D., Ph.D., is a pediatrician and clinical geneticist. He is an Associate Professor at the Center for Medical Genetics at Shinshu University Hospital, where he directs clinical service for heritable connective tissue disorders and research especially on D4ST1-deficient EDS. Dr. Roberto Mendoza-Londono, M.D., is the Director of the EDS clinic at the Hospital for Sick Children (HSC) and University Health Network (UHN) in Toronto and the interim head of the Division of Clinical of Metabolic Genetics at HSC/University of Toronto. He is a clinical geneticist with expertise in skeletal dysplasia's and connective tissue disorders who has an interest in gene discovery and studies of natural history of disease. He has participated in several collaborative projects that led to the identification and characterization of genes that regulate the formation and maintenance of bone and connective tissue. Prof. Michael F. Pope, M.B.B.Ch., F.R.C.P., M.D., is Consultant in Charge of the new NHS National Commissioning Group Complex EDS Service at the Kennedy Galton Center, Northwick Park Hospital. He is especially interested in the classification, genetics, and diagnosis of Ehlers–Danlos syndrome, osteogenesis imperfecta, pseudoxanthoma elasticum, cutis laxa, Stickler syndrome, the Marfan syndrome, many of which overlap with the benign hypermobility syndrome (BHS). His expertise lies in the differentiation, separation, and testing of these disorders from BHS. Dr. Marianne Rohrbach, M.D., Ph.D. in molecular genetics, is a trained pediatrician and clinical geneticist. Together with Dr. Giunta, she leads the diagnostic and research activities of the Connective Tissue Unit at University Children's Hospital in Zurich, Switzerland. Dr. Rohrbach established a multidisciplinary Connective tissue clinic including clinical, biochemical, and molecular diagnosis, as well as patient management and counseling. Her research focus includes long-term follow up and natural history of all connective tissues diseases and the understanding of the Molecular Basis and Pathology of Connective Tissue Disorders, in particular the rare forms of EDS and osteogenesis imperfecta. Dr. Tim Van Damme is an M.D., Ph.D. student at the Center for Medical Genetics Ghent, Belgium, whose research involves the study of clinical, genetic and pathogenetic aspects of the Ehlers–Danlos syndromes and related disorders. Dr. Anthony Vandersteen, M.A., Ph.D., M.D., is a medical geneticist, assistant professor at IWK Health Center and Dalhousie University, Nova Scotia, Canada. He has a special interest in EDS and previously worked in the UK National EDS Diagnostic Service. Caroline van Mourik, B.Ed., M.Sc., Ph.D. (Biology and Geology), has been active in the Swedish patient-organization, previously as Chair but later mainly as the scientific editor. She even presented a paper at the first international symposium on EDS in Ghent, 2012 and frequently lectures about EDS, both for the medical field as well as laymen. Nicol Voermans, M.D., Ph.D., is a neurologist specialized in neuromuscular disorders at the Radboud University Medical Center (Nijmegen, the Netherlands). She directs the clinical service for neurological and neuromuscular features of various types of EDS, and has a large experience with the TNX-deficient type EDS. Prof. Johannes Zschocke, M.D., Ph.D., is Professor and Chair of Human Genetics at the Medical University Innsbruck, Austria, where he is also Acting Director of the Department of Medical Genetics, Molecular and Clinical Pharmacology. As Head of the Center for Medical Genetics Innsbruck, he is responsible for the provision of genetic services for the Western Austria and beyond. His clinical and research focus is on inherited metabolic diseases, and he has been involved in the genetic characterization of several Ehlers–Danlos Syndrome subtypes. Prof. Fransiska Malfait, M.D., Ph.D., is a rheumatologist and clinical geneticist. She is an Associate Professor at the Center for Medical Genetics at the Ghent University Hospital, where she directs the research, clinical service, and laboratory facility for diagnosis and genetic testing for the Ehlers–Danlos syndrome and other heritable disorders of connective tissue. She is the current Chair of the medical and scientific board of the Ehlers–Danlos Society. *Correspondence to: Fransiska Malfait, M.D., Ph.D., Center for Medical Genetics, Ghent University Hospital, De Pintelaan 185, Gent 9000, Belgium. E-mail: [email protected] DOI 10.1002/ajmg.c.31550 Article first published online in Wiley Online Library (wileyonlinelibrary.com).
ß 2017 Wiley Periodicals, Inc. RESEARCH REVIEW AMERICAN JOURNAL OF MEDICAL GENETICS PART C (SEMINARS IN MEDICAL GENETICS) 71
The Ehlers–Danlos syndromes comprise a clinically and genetically heterogeneous group of heritable connective tissue disorders, which are characterized by joint hypermobility, skin hyperextensibility, and tissue friability. In the Villefranche Nosology, six subtypes were recognized: The classical, hypermobile, vascular, kyphoscoliotic, arthrochalasis, and dermatosparaxis subtypes of EDS. Except for the hypermobile subtype, defects had been identified in fibrillar collagens or in collagen-modifying enzymes. Since 1997, a whole spectrum of novel, clinically overlapping, rare EDS-variants have been delineated and genetic defects have been identified in an array of other extracellular matrix genes. Advances in molecular testing have made it possible to now identify the causative mutation for many patients presenting these phenotypes. The aim of this literature review is to summarize the current knowledge on the rare EDS subtypes and highlight areas for future research. © 2017 Wiley Periodicals, Inc.
KEY WORDS: Ehlers–Danlos syndromes; heritable connective tissue disorders; collagen How to cite this article: Brady AF, Demirdas S, Fournel-Gigleux S, Ghali N, Giunta C, Kapferer-Seebacher I, Kosho T, Mendoza-Londono R, Pope MF, Rohrbach M, Van Damme T, Vandersteen A, van Mourik C, Voermans N, Zschocke J, Malfait F. 2017. The Ehlers–Danlos syndromes, rare types. Am J Med Genet Part C Semin Med Genet 175C:70–115.
INTRODUCTORY Brittle cornea syndrome (BCS): Ma- substitutions in the proa1(I) chain of type STATEMENT rianne Rohrbach, Tim Van Damme I collagen, c.1720C>T, p.(Arg574Cys) Spondylodysplastic EDS (spEDS- and c.3277C>T, p.(Arg1093Cys°), were For each genetic EDS subtype, a sub- B4GALT7 and spEDS-B3GALT6): identified in two other adults with committee of authors performed a com- Sylvie Fournel-Gigleux, Tim Van vascular rupture, but without EDS-signs prehensive literature search. All articles Damme, Fransiska Malfait [Malfait et al., 2007]. The p.(Arg312Cys) were reviewed for relevance and addi- Spondylodysplastic EDS (spEDS- mutation has subsequently been identi- tional articles were identified from the SLC39A13): Cecilia Giunta fied in two other individuals with EDS literature. The articles were summarized Musculocontractural (mcEDS): To- and complications of vascular fragility and divided into themes: (1) the historyof moki Kosho, Fransiska Malfait [Ritelli et al., 2013; Gaines et al., 2015]. the EDS subtype, (2) mechanisms of Myopathic EDS (mEDS): Roberto In view of the major clinical overlap of disease, (3) allelic heterogeneity, (4) Mendoza-Londono, Fransiska Malfait the p.(Arg312Cys)-associated phenotype clinical description, (5) genotype–phe- Periodontal EDS (pEDS): Ines Kapferer- with classical EDS due to COL5A1 or notype correlations and penetrance, (6) Seebacher, Michael Pope, Anthony Van- COL5A2 mutations, both conditions management, and (7) differential diagno- dersteen, Johannes Zschocke are grouped within the same clinical sis. The summary of these themes was entity (“Classical EDS”) in the new critically reviewed by all authors. EDS classification. Patients with the Subcommittees: CLASSICAL EDS DUE TO p.(Arg312Cys) mutation are particularly COL1A1 p.(Arg312Cys) at risk for vascular events, highlighting the (COL1A1-cEDS) Classical EDS due to COL1A1 benefit of molecular confirmation in p.(Arg312Cys) (cEDS-COL1A1): Synonyms: Classic-like Ehlers–Danlos classical EDS patients for management Fransiska Malfait syndrome with propensity to arterial purposes. Classical-like EDS due to Tenascin-X rupture, Vascular-like EDS deficiency (clEDS): Serwet Demirdas, Nicol Voermans The History of Classical EDS Cardiac-valvular EDS (cvEDS): Fran- In view of the major clinical due to COL1A1 p.(Arg312Cys) siska Malfait overlap of the p.(Arg312Cys)- (COL1A1-cEDS) Arthrochalasia EDS (aEDS): Tomoki associated phenotype with Kosho, Cecilia Giunta, Marianne Nuytinck et al. [2000] reported two Rohrbach, Fransiska Malfait children with a classical EDS phenotype, classical EDS due to COL5A1 Dermatosparaxis EDS (dEDS): Tim including skin hyperextensibility, easy or COL5A2 mutations, both Van Damme, Fransiska Malfait bruising, atrophic scarring, and joint Kyphoscoliotic EDS (kEDS-PLOD1): hypermobility, with a c.934C>T, conditions are grouped within Angela Brady, Neeti Ghali, Cecila p.(Arg312Cys) mutation. Malfait et al. the same clinical entity Giunta, Marianne Rohrbach, Tim [2007] identified the same mutation in “ ” Van Damme, Anthony Vandersteen an adult who suffered from a rupture ( Classical EDS ) in the new Kyphoscoliotic EDS (kEDS-FKBP14): of medium-sized arteries, reminiscent EDS classification. Cecila Giunta, Marianne Rohrbach, of vascular EDS. In addition, two Tim Van Damme, Fransiska Malfait other arginine-to-cysteine (Arg-to-Cys) 72 AMERICAN JOURNAL OF MEDICAL GENETICS PART C (SEMINARS IN MEDICAL GENETICS) RESEARCH REVIEW
The prevalence of this condition is with other EDS signs. It is a rare, but spontaneous dissection of the right iliac unknown. important differential diagnosis of vas- artery at 43 years. Her affected 16-year- cular EDS. old son did not have complications of Mechanism of Disease vascular fragility, except for unusual Reported clinical features for the bruising. The patient, reported by The pathogenetic basis for the phenotype p.(Arg312Cys) substitution Gaines et al. [2015] suffered from a resulting from these specific Arg-to-Cys spontaneous rupture of the common substitutions is currently not well under- Reproductive, including pregnancy iliac artery at 39 years. The patient, stood. Ultrastructural studies of dermal Premature preterm rupture of the fetal reported by Ritelli et al. [2013] had collagen fibrils have shown fibrils membranes (PPROM) was reported in mild mitral and aortic valve regurgita- with variable diameters, and slightly one patient. One patient was reported tion, left ventricular wall thickening, irregular contour, and, in case of the to have neonatal hypotonia. No preg- aortic root dilatation, vertebral artery p.(Arg312Cys), flower-like abnormali- nancy-related complications were re- tortuosity, and a hepatic hemangioma at ties [Malfait et al., 2007]. ported (one known pregnancy in an 53 years. The two children reported by Several mechanisms have been sug- affected female). Nuytinck et al. [2000] did not show gested to be involved in the pathogenesis Craniofacial features signs of vascular fragility at the time of [Malfait et al., 2007], including local None of the patients had characteristic report. Clinical follow-up is not avail- destabilization of the triple helix due to features of vascular EDS. One patient able for these patients. loss of the stabilizing arginine residue; was reported to have redundant skin introduction of a cysteine residue, which folds on the eyelids and soft earlobes, can lead to disulfide-bonding with reminiscent of classical EDS. One Other Arg-to-Cys substitutions that lead to other collagenous or non-collagenous patient had blue sclerae, high palate, vascular fragility proteins, either intracellularly or in the and hypoplastic uvula. EDS-like signs have only been observed extracellular matrix (ECM), thereby Musculoskeletal system in association with the p.(Arg312Cys) disturbing normal physiological interac- Generalized joint hypermobility was mutation. One patient harboring a tions; interference with pericellular reported in four patients. One patient p.(Arg574Cys) (male, 42 years) suffered processing of the amino-propeptide of had congenital bilateral hip dislocation from a dissection of the left femoral procollagen type I, and/or local unwind- and a traumatic shoulder dislocation. artery and an aortic aneurysm. One ing of the region surrounding the Another patient was also reported to patient harboring a p.(Arg1093Cys) mutations, thereby disturbing specific have sporadic joint dislocations. Pectus (male, 40 years) had a left kidney interactions with type I collagen ligands excavatum was reported twice. Two infarction at age 34 years, and a [Malfait et al., 2007]. patients complained from chronic joint dissection of the infrarenal aorta and pain. None of the patients had a history left iliac artery, with aneurysm of the left Allelic Heterogeneity of fractures; DEXA Z-score was normal renal artery at age 39 years. He also had Three different heterozygous COL1A1 in two patients. mitral valve bulging [Malfait et al., mutations, leading to a Arg-to-Cys Skin and integument 2007]. substitution have been reported in Skin involvement included skin hyper- ¼ association with vascular fragility: extensibility (n 4); soft, doughy skin – ¼ ¼ Genotype Phenotype Correlation c.934C>T, p.(Arg312Cys); c.1720C>T, (n 2); thin or translucent skin (n 3); ¼ and Penetrance p.(Arg574Cys); and c.3277C>T, p. friable skin/skin splitting (n 2); atro- ¼ a (Arg1093Cys). phic scars (n 4); delayed wound heal- The Arg-to-Cys substitutions in the 1 ing (n ¼ 1); unusual tenderness upon (I) collagen chain seem to be associated touch (hyperalgesia) (n ¼ 1); piezogenic with specific phenotypes: Classical EDS Clinical Description papules (n ¼ 1); molluscoid pseudotu- with vascular fragility for p.(Arg312Cys) To date, six patients from five families mors (n ¼ 1); varicose veins (n ¼ 1). Easy and isolated vascular fragility for have been reported with the p. bruising was reported in all patients p.(Arg574Cys) and p.(Arg1093Cys). (Arg312Cys) (Table S1). These include (n ¼ 6). Finallyone patient had hiatal and In addition, three other Arg-to-Cys two females (respectively 5 and 43 years abdominal and inguinal hernias. substitutions have been reported for old) and five males (respectively 7, 16, Ocular involvement this gene: c.3040C>T,p.(Arg1014Cys) 39, and 53 years old). [Nuytinck et al., Blue sclerae were observed on one is associated with autosomal dominant 2000; Malfait et al., 2007; Ritelli et al., patient. One patient was operated for Caffey disease [Gensure et al., 2005], 2013; Gaines et al., 2015]. strabismus. whereas c.3106C>T,p.(Arg1036Cys) The hallmark of this condition is Cardiovascular system and c.3196C>T,p.(Arg1066Cys) are the “vascular fragility,” leading to spon- All three adults had severe cardiovascu- reported in patients with an OI/EDS taneous dissection or rupture of lar complications. The patient repo- overlap phenotype without signs of medium-sized arteries, in combination rted by Malfait et al. [2007] had a vascular fragility [Cabral et al., 2007; RESEARCH REVIEW AMERICAN JOURNAL OF MEDICAL GENETICS PART C (SEMINARS IN MEDICAL GENETICS) 73
Lund et al., 2008]. The pathogenic basis (CAH) due to 21-hydroxylase defi- Allelic Heterogeneity for theses specific clinical consequences ciency as well as hyperextensible skin, A total of 24 patients with a complete is unknown. hypermobile joints, easy bruising, TNX-deficiency without involvement Penetrance is unknown. and poor wound healing. Skin biopsy of the CYP21B gene have been of this patient showed small collagen reported. In 19 of these patients (15 fibers of normal shape and a complete Management families), the molecular diagnosis is absence of tenascin XB (TNX). known. Homozygous and compound Key management guidelines focus on Cultured dermal fibroblasts also heterozygous mutations have been iden- the cardiovascular system. lacked TNX. PCR of the patients tified. Mutations have been identified Specific management guidelines DNA revealed a 30 kb deletion in throughout the TNXB gene, and in- include: chromosome 6 overlapping both the clude missense, frameshift, and nonsense CYP21B gene and the TNXB mutations. – Measurement of aortic root size and gene. Subsequently, Schalkwijk et al. There is a registry of reported assessment of heart valves by echocar- [2001] measured TNX in the serum of TNXB gene variants [Dalgleish, 1998]. diogram at the time of diagnosis or by 151 EDS patients (classical and vascular In five out of the 24 reported age 5 years type), 168 diseased controls (psoriasis patients, no genetic confirmation of – Echocardiogram at 5-year intervals, and rheumatoid arthritis), and 21 the clinical diagnosis after TNX serum even if the initial echocardiogram is healthy controls. They detected a measurement was performed. normal complete TNX deficiency in five – Vigilant observation and control of EDS patients and three affected blood pressure can reduce the risk of siblings (one of which with the contig- Clinical Description arterial rupture uous gene syndrome). Mutation analy- The clinical phenotype of the 24 – Further vascular surveillance ought to ses revealed mostly homozygous patients with a complete TNX- be considered mutations in the TNXB gene for deficiency without involvement of the – Consider bone densitometry evaluation these patients. The authors concluded CYP21B gene was reviewed (Table S1) that the TNX-deficient type is very [Schalkwijk et al., 2001; Peeters et al., Guidelines for management of similar to the classical type of EDS with 2004; Lindor and Bristow, 2005; Voer- musculoskeletal problems, skin in- two major differences: (1) No atrophic mans et al., 2007, 2009b; O’Connell volvement, ophthalmologic and dental scarring was apparent, and (2) the et al., 2010; Hendriks et al., 2012, follow-up, and pregnancy should fol- inheritance pattern was autosomal P enisson-Besnier et al., 2013; Sakiyama low those formulated for other forms recessive. et al., 2015; Demirdas et al., 2016]. of EDS (for reference: See “manage- The prevalence of this condition is The absence of TNX throughout ment guidelines for the classical unknown. the body leads to a phenotype resem- Ehlers–Danlos syndrome,” by Bowen bling the classical type of EDS. The et al., this issue). Mechanism of Disease hallmarks of the disorders are GJH, hyperextensible, soft and/or velvety TNX is one of the three known large Differential Diagnosis skin, without the typical atrophic scar- matricellular proteins of the tenascin ring seen in classical EDS, easy bruising, family [Mao and Bristow, 2001; and an autosomal recessive inheritance Vascular EDS Valcourt et al., 2015]. Although the pattern. Classical EDS due to COL5A1 or precise function of TNX is unknown, COL5A2 mutations it is known to play a role in the ECM OI as it is highly expressed in connective Reproductive, including pregnancy tissue of muscle, around tendons, Egging et al. [2008] retrospectively ligaments,andinskin[Maoand investigated genitourinary and obstetric Bristow, 2001]. The glycoprotein is complications in seven women with CLASSICAL-LIKE EDS encoded by the TNXB gene in classical-like EDS, aged 38–57 years (six DUE TO TENASCIN-X humans. Classical-like EDS is caused from the cohort of Schalkwijk et al. DEFICIENCY (clEDS) byacompletelackofTNXdueto [2001] and Patient 1 from the series of homozygous or compound heterozy- Lindor and Bristow [2005]). These The History of the Classical-Like gous TNXB mutations, that lead to women have had a total of 13 pregnan- EDS nonsense-mediated mRNA decay cies and 12 deliveries. Two women (one This type of EDS was first described by (NMD), or biallelic deletion of with CAH due to 21-hydroxylase Burch et al. [1997]. The authors TNXB. As a result, the TNX protein deficiency as a contiguous gene syn- described a 26-year-old male patient is completely absent [Mao and Bris- drome; one with additional spina bifida with congenital adrenal hyperplasia tow, 2001]. who decided to have no biological 74 AMERICAN JOURNAL OF MEDICAL GENETICS PART C (SEMINARS IN MEDICAL GENETICS) RESEARCH REVIEW
children) did not have any pregnancies. of age by O’Connell et al. [2010]. patients from the cohort of Demirdas One out of 13 pregnancies ended in Furthermore, in some adult cases, a et al. [2016] were described to have intrauterine death of the fetus, and one childhood onset of hypermobility and frequent subconjunctival hemorrhage. out of 12 deliveries was complicated dermatological symptoms was reported. Dental involvement with post-partum hemorrhage. No Demirdas et al. [2016] reported that all Recurrent periodontitis was reported in premature births or neonatal complica- patients (n ¼ 17) had a clinical onset in one, and another patient was described tions were reported. No urinary incon- childhood, ranging from the neonatal to have dental crowding due to a narrow tinence was seen. Vaginal (n ¼ 1), age to puberty. The most encountered palate. uterine (n ¼ 2), and rectal (n ¼ 1) initial symptoms in this group were Cardiovascular system prolapse were present. One undefined (sub)luxations, hypermobility, and vel- Peeters et al. [2004] investigated the prolapse was mentioned. Three out of vety/hyperextensible skin. Based on the cardiac features in seven TNX-deficient five women had partus-related compli- data we found, we conclude that patients (all from the cohort of Schalk- cations (vaginal uterine extirpation after patients already experience symptoms wijk et al. [2001]). They found a systolic uterine prolapse, post-partum hemor- such as skin hyperextensibility, a velvety murmur at the apex in one patient. rhage, intra-uterine death at 24 weeks skin, easy bruising/spontaneous ecchy- Three of the seven patients were found with post-partum hemorrhage, and mosis, subluxations, and joint hyper- to have mitral valve abnormalities precipitous second stage during at mobility in childhood. Piezogenic (billowing of the mitral valve in two term deliveries). The authors con- papules of the feet and pes planus are patients of the same family and a severe cluded that pregnancy is without major also apparent at the pediatric age. mitral valve prolapse (MVP) in another complications in TNX-deficient pa- Craniofacial features patient). Although the number of tients, apart from one incident of Craniofacial features reported in the patients was small and such abnormali- postpartum hemorrhage. However, patients included a slight asymmetry of ties are not infrequent in the general uterine and vaginal prolapse regularly the face (n ¼ 1), lax skin of the cheeks population, the authors recommended occurs in TNX-deficient women, even (n ¼ 1), and a narrow and/or high echocardiography at baseline and if a at a young age, suggesting laxity of the arched palate (n ¼ 4). cardiac murmur appears [Peeters et al., genitourinary tissues. Furthermore, no Musculoskeletal system 2004]. Subsequently, Lindor and Bristow premature births have been observed in Frequently described musculoskeletal [2005] also described a patient who had the offspring; however, some patients features included joint and/or muscular mitralvalvesurgeryduetoaMVP. had been born prematurely themselves. pains. Furthermore, one paper reported Demirdas et al. [2016] also described Demirdas et al. [2016] described the frequently observed deformities of the cardiologic features of their patients. Four gynecologic and obstetric history of hands and feet. Twelve out of 17 out of 17 of the patients had hypertension seven women in their cohort. Three of included patients had pes planus and and two patients (4/17 patients were these women had previously been four patients had short/broad feet with previously included by Peeters et al. included in the study by Egging et al. brachydactyly of the toes. Four of the [2004]) had mitral valve abnormalities. [2008]. The other four women reported patients had deformities of the fingers One patient developed a post-partum a total of 10 pregnancies, two of which and acrogeric hands [Demirdas et al., cardiomyopathy [Demirdas et al., 2016]. ended in intrauterine demise of the 2016]. Gastrointestinal system fetus. Furthermore, four out of 10 Skin and integument Two patients reported by Lindor and deliveries were complicated with post- It is noted that all reported patients had Bristow [2005] suffered from bleeding of partum hemorrhage, two women had hyperextensible skin, frequently de- gastrointestinal structures, namely the perineal rupture, and one pregnancy scribed to be soft and velvety of sigmoid and duodenum, secondary to was complicated by PPROM. In this structure. The atrophic scars typical diverticulitis and as complications of cohort, another woman was reported to for classical EDS were not observed. spontaneous ileus. Hendriks et al. have pelvic instability without ever Bilateral inguinal hernia was described [2012] reported a gastric hemorrhage having been pregnant [Egging et al., in a male patient and unilaterally in a duetoulcersinamalepatientinitially 2008]. female patient. An umbilical hernia was reported by Schalkwijk et al. [2001]. He Obviously, some caution must be described in a 6-year-old male. died at the age of 57 years due to a septic taken in making conclusions and ex- Ocular involvement shock following elective mitral valve trapolating data from such a small group Ocular involvement was infrequently replacement surgery, which was compli- of TNX-deficient patients (n ¼ 11) reported in patients with TNX-defi- cated by a sinuspiriformis perforation by [Egging et al., 2008]. cient classical-like EDS. One patient a transesophageal ultrasound probe Age of onset was described to have esotropia/ambly- [Hendriks et al., 2012; Knuijt et al., Symptoms of patients with the TNX- opia [Lindor and Bristow, 2005], an- 2014]. Sakiyama et al. [2015] also pre- deficiency have been described as other to have astigmatism, and a third sented a patient who had recurrent starting as early as 5 years of age in a patient was described to have bilateral gastrointestinal perforation due to tissue girl by Hendriks et al. [2012] and 7 years conjunctivochalasis. Five out of 17 fragility (diverticulitis, spontaneous ileus RESEARCH REVIEW AMERICAN JOURNAL OF MEDICAL GENETICS PART C (SEMINARS IN MEDICAL GENETICS) 75
and a subsequent perforation of the (one of the cohort of Schalkwijk et al. reported hypermobile joints [Demirdas duodenum). Demirdas et al. [2016] did [2001] and three of the other patients et al., 2016]. not observe severe gastrointestinal in the study of Voermans et al. problems in their patients. However, [2009b] showing that in response to one patient had a gastric ulcer at age 16 the increased compliance of the Genotype–Phenotype Correlations and a bowel perforation due to extracellular matrix in muscle of and Penetrance diverticulitis at age 48 years [Demirdas TNX-deficient EDS patients, a et al., 2016]. marked intracellular stiffening of the No genotype–phenotype correlations Neuromuscular features and motor sarcomere protein titin occurs. The are reported within the group. We development stiffening of titin most likely com- assume that penetrance is high, but the A total of six articles describe pensates for the muscle weakness research to support this assumption is research concerning muscular func- [Ottenheijm et al., 2012]. The lacking. Family members with a hap- tion in patients with TNX-deficiency report by P enisson-Besnier et al. loinsufficient mutation in the TNXB or their muscle tissue [Voermans [2013] presented a 42-year-old gene have been described to have et al., 2007, 2009b; Ottenheijm male patient with proximal limb symptoms of joint hypermobility in et al., 2012; Gerrits et al., 2013; muscle weakness, subclinical heart 60% of the cases, but more research is P enisson-Besnier et al., 2013; involvement, minimal skin hyperex- needed to confirm this [Zweers et al., Sakiyama et al., 2015]. All papers tensibility, no joint abnormalities, 2003]. concludethatthereissomedegreeof and a history of easy bruising. He muscle weakness in patients with had been asymptomatic until age 30 Management TNX-deficiency. Voermans et al. but mentioned low performances [2007] studied a cohort of 40 EDS at upper bodybuilding exercises. No specific guidelines for management patients, among which 10 with Since then, he experienced gradually of patients with classical-like EDS are TNX-deficiency (six of the cohort worsening lower limb weakness, lead- available. Guidelines for management of Schalkwijk et al. [2001], and four ing to inability to run from age 40, of musculoskeletal problems, skin in- additional patients). Muscle weakness, frequent falls, and the recent need of a volvement, cardiovascular involve- myalgia, and easy fatigability were banister for stairs. He was initially ment, and pregnancy should follow reported by the majority of patients, diagnosed as having a primary myop- those formulated for other forms of whereas all patients were able to walk athy and only later diagnosed EDS (for reference: See “management independently without aids. Mild-to- with EDS [P enisson-Besnier et al., guidelines for the classical Ehlers– moderate muscle weakness (80%) and 2013]. Danlos syndrome,” by Bowen et al., reduction of vibration sense (60%) Motor development was not stud- this issue). were common. Other findings were ied in the included papers. We detected Specific management guidelines axonal polyneuropathy (40%) on no comments on delayed motor devel- may include: nerve conduction studies and mild opment other than mild to moderate myopathic features on muscle biopsy muscle weakness. Musculoskeletal (20%). Patients with hypermobile Neurological features and neuromotor In case of operations, special attention EDS (hEDS) caused by TNXB hap- development for the effect of general anesthesia and of loinsufficiency were less affected Cognitive development was not studied adequate positioning and support is [Voermans et al., 2009b]. This was in the included papers. Intellectual important to prevent pressure or stretch confirmed in a quantitative study on disability was not reported. neuropathies [Voermans et al., 2006]. isometric function of the thigh Other Furthermore, intubation and endo- muscles in seven patients (four of Severe edema of the ankles and/or feet scopic studies should be performed the cohort of Schalkwijk et al. was described in four patients. carefully in order to prevent rupture of [2001] and three of the other patients Family history trachea or esophagus [Besselink-Loba- in the study of Voermans et al. Demirdas et al. [2016] asked their nova et al., 2010; Hendriks et al., 2012] [2009b] and Gerrits et al. [2013]). patients about family history and found Pregnancy The results showed that muscle that 4/11 mothers and 5/11 fathers Gynecological follow-up throughout weakness in this type of EDS is complained of (sub)luxations (n ¼ 4), pregnancy is not warranted based on most likely due to increased compli- pes planus (n ¼ 2), easy bruising (n ¼ 1), the retrospective study in five patients ance of the series-elastic component artralgia (n ¼ 4), hyperextensible skin [Egging et al., 2008]. However, the of muscle tissue and failure of maxi- (n ¼ 3), hypermobility (n ¼ 1), and severe complications that have been mal voluntary muscle activation. Fur- inguinal hernia (n ¼ 1). Of the 17 reported during insertion of a trachea ther proof of this concept was patient’s siblings, 11 out of 26 were tube and a transesophageal ultrasound obtained in single fiber study of tested and proven heterozygous car- probe call for a very careful handling muscle tissue of four of these patients riers. Three of these 11 carrier siblings of patients, especially in emergency 76 AMERICAN JOURNAL OF MEDICAL GENETICS PART C (SEMINARS IN MEDICAL GENETICS) RESEARCH REVIEW
situations. Therefore, we advise a clini- during intubation. During elective carried a contiguous deletion that cal delivery for all patients surgery at the age of 41 years (because extended into TNXB. One patient of a luxation of the left knee joint) a carried a TNXB premature stop codon. tracheal rupture developed, despite Twelve of 13 patients with CAH-X had the initially uneventful intubation. EDS clinical features. Patients with Differential Diagnosis The authors acknowledge that the CAH-X were more likely than age- patient had other anatomic risk factors matched controls to have joint hyper- Classical EDS for a tracheal rupture (obesity and mobility (P < 0.001), chronic joint pain Congenital myopathies, including col- short stature for example). However, (P ¼ 0.003), multiple joint dislocations lagen VI- and collagen XII-related the authors also state that TNX alters (P ¼ 0.004), a structural cardiac valve disorders the characteristics of the ECM and abnormality by echocardiography therefore advise caution when intu- (P ¼0.02), and reduced TNX expres- bating patients with TNX-deficiency, sion by Western blot and immuno- THE CONTIGUOUS or even to refrain from intubating staining. Piezogenic papules on the feet GENE SYNDROME WITH entirely [Besselink-Lobanova et al., were also observed. A subset of parents CONGENITAL ADRENAL 2010]. was investigated (five mothers, two HYPERPLASIA AND fathers), of which three had GJH with TNX-DEFICIENCY a Beighton score of 5 or more [Merke TNXB Haploinsufficiency Burch et al. [1997] first described the et al., 2013]. TNX-deficient pheno- and genotype in Zweers et al. [2003] studied the 20 Morissette et al. [2015] investigated a male patient (26 years old) with heterozygous family members of the the genetic background of this cohort hyperextensible skin, hypermobile index cases in Schalkwijk et al. in the same natural history study joints, easy bruising and 21-hydroxylase [2001] regardless of clinical symptoms. (n ¼ 246). Seven families (10 patients) deficiency. A heterozygous 30 kb dele- In all of these individuals, significantly harbored a novel TNXB missense tion was found on chromosome 6 reduced serum TNX levels were variant c.12174C>G,p.(Cys4058Trp) involving both the CYP21B gene and detected, and in 17 of them, they and had a clinical phenotype consistent the TNX gene as a causative explanation confirmed heterozygosity for a trun- with hEDS. Fourteen CAH probands for all symptoms. They also reported cating TNXB mutation. Clinical ex- carried previously described TNXA/ that TNX in serum, skin and muscle was amination in these family members TNXB chimeras, resulting in a CAH- measured and absent. The authors showed generalized joint hypermobil- X prevalence of 8.5%. This highly concluded that a small deletion or ity (GJH) in nine family members conserved pseudogene-derived variant missense mutation had probably re- (45%; all female). Skin hyperextensi- in the TNX fibrinogen-like domain is mained undetected on the maternal bility and easy bruising, frequently seen predicted to be deleterious and disul- allele [Burch et al., 1997]. in the individuals with complete TNX fide-bonded, resulting in reduced der- The second patient with this deficiency, were absent. Subsequently, mal elastin and fibrillin-1 staining and Continuous gene syndrome was in- they measured serum TNX levels (by altered TGF-1 binding, and represents cluded in the initial series of Schalk- ELISA) in an unselected cohort of 80 anovelTNXA/TNXB chimera. TNX wijk et al. [2001] (Patient 3) and patients with hEDS. Six of these protein expression was normal in subsequent cohorts [Egging et al., patients (7.5%; all female) had serum dermal fibroblasts, suggesting a domi- 2008; Voermans et al., 2009b; Gerrits TNX levels more than 2.5 SD below nant-negative effect. They concluded et al., 2013]. She was homozygous for the mean for unaffected individuals. that the CAH-X syndrome is com- the 30-kb deletion detected in the Clinically, patients with reduced TNX monly found in CAH due to 21- index case reported by Bristow. Both levels showed hypermobile joints, of- hydroxylase deficiency and may result her parents and two siblings were ten associated with joint subluxations from various etiological mechanisms heterozygous for the deletion and and chronic musculoskeletal pain. The [Morissette et al., 2015]. Patients in this were clinically normal, providing evi- authors concluded that TNXB hap- cohort were considered to be hetero- dence of recessive inheritance in this loinsufficiency is associated with hEDS zygous for the TNXB deletion, and family. This 32-year female patient [Zweers et al., 2003]. had reduced but not absent TNX levels was described to have recurrent (sub) Merke et al. [2013] investigated the in serum. Therefore, this phenotype is luxations, hypermobile joints, hyper- prevalence of a Continuous gene syn- likely be more in line with what is extensible, and velvety skin that drome in a cohort of 192 consecutive reported by Zweers et al. [2003] in easily bruises, musculoskeletal pain, unrelated CAH patients. TNXB hap- patients with reduced serum levels of and CAH. Besselink-Lobanova et al. loinsufficiency, here termed CAH-X TNX, and with the reported features [2010] presented the follow-up of this syndrome, was present in 13 patients in some of the sibs who are obligate case in order to draw attention to (and two sibs). Twelve of 91 patients carriers of the mutation in their the severe complications encountered carrying a CYP21A2 deletion (13%) affected family member. RESEARCH REVIEW AMERICAN JOURNAL OF MEDICAL GENETICS PART C (SEMINARS IN MEDICAL GENETICS) 77
CARDIAC-VALVULAR EDS escapes nonsense-mediated mRNA de- small joints. One patient had shoulder (cvEDS) cay (NMD) and the mRNA is stable, but dislocations, pectus excavatum, and the proa2(I) chains fail to fold normally muscle and tendon tears. One patient History of Cardiac-Valvular EDS and are degraded, which eventually also had recurrent patellar dislocations. Foot results in the production of pro-a1(I) deformities were reported in three In 1987 and 1988, Sasaki et al. [1987], homotrimers [Pihlajaniemi et al., 1984]. patients: A 6-year-old boy displayed Kojima et al. [1988], and Hata et al. Given that proa(I) homotrimer forma- pes planus with valgus heels, hallux [1988] reported two Japanese patients tion alone does not lead to OI, the OI valgus, and subluxations of the toes; a with complete absence of the proa2(I) phenotype in the latter patient suggests 9-year-old girl had pedes palonvalgi collagen chains, both presenting EDS- that the intracellular accumulation of with secondary shortening of Achilles like features, including joint hypermobil- mutant proa2(I) chains and the cellular tendon; and in an adult man pes planus ity, skin hyperextensibility, abnormal alterations, resulting from a high rate of and calcaneovalgus were reported. One wound healing, but also cardiac-valvular degradation of these chains, contributes patient had increased bone fragility. problems. Nicholls et al. [2001]reported a to the skeletal phenotype. In contrast, Skin and integument total absence of a2(I) collagen chains in a the EDS phenotype that results from Reported skin abnormalities included: 9-year-old girl with phenotypic manifes- unstable mRNA and no proa2(I) chains Skin hyperextensibility (n ¼ 4) (ranging tationsofbothOIandEDS,butwithout reflects what appears to be a more from mild to severe), soft skin (n ¼ 2), cardiovascular anomalies. A homozygous limited response in the ECM. atrophic scar formation (classical EDS- splice site mutation led to the introduc- like) (n ¼ 2), easy bruising (n ¼ 2) tion of a premature termination codon delayed wound healing (n ¼ 1), thin (PTC). Schwarze et al. [2004] reported Allelic Heterogeneity skin (n ¼ 1), striae (n ¼ 1). Inguinal four patients from three independent Seven different mutations have been hernia was reported in two males, families (including the patient reported reported in five independent cardiac- including congenital bilateral inguinal by Kojima et al. [1988]) with a rare, valvular EDS patients. These include hernia in one. recessively inherited form of EDS, char- one homozygous nonsense mutation Ocular involvement acterized by joint hypermobility, skin (c.213dupC,p.(Arg99 )), and six splice Myopia and astigmatism was reported in hyperextensibility, and severe cardiac- site mutations (two homozygous one patient; one patient was reported to valvular defects, resulting from biallelic (c.3105þ2T>C and c.3601G>T)) and have blue sclerae. COL1A2 mutations, leading to complete two compound heterozygous Cardiovascular system absence of proa2(I)-chains. Because of (c.70þ717A>G; c.1404þ1G>A and All four reported adults had severe the severe cardiac valve problems in most c.540þ5G>A; c.1404G>C). The pa- cardiac-valvular problems, resulting in of the adult patients, this phenotype was tient reported by Sasaki et al. [1987] was valve replacement surgery.A 45-year-old called “cardiac-valvular EDS” [Schwarze only analyzed at the biochemical level male had severe mitral valve regurgitation et al., 2004]. One additional child with and no molecular data were reported. due to MVP,resulting in left atrium and this condition was subsequently reported ventricle dilatation and mild ventricular by Malfait et al. [2006]. hypertrophy. He also had aortic valve The exact prevalence of this rare Clinical Description insufficiency, eventually necessitating condition is unknown. To date, six patients from five indepen- mitral and aortic valve replacement. dent families have been reported Post-surgery, there was dehiscence of Mechanism of Disease (Table S1). Their age at diagnosis ranged the mitral annulus from the ventricle, and The biallelic COL1A2 mutations result from 6 to 65 years [Hata et al., 1988; of the aortic valve from the atrioventric- in the complete absence of proa2(I)- Kojima et al., 1988; Nicholls et al., ular groove. Finally, there was massive chains. Cells from affected individuals 2001; Schwarze et al., 2004; Malfait leakage through the left ventricular produce type I collagen molecules that et al., 2006]. myocardium with disintegration of the contain only proa1(I) chains. The The hallmark of the condition is the entire left ventricle, from which the mRNA from the mutant alleles is severe cardiac-valvular disease, necessi- patient died. A 65-year-old woman had unstable and degraded so that no protein tating valve replacement surgery at adult mitral valve insufficiency with uncom- is produced. Nicholls et al. [1984] age, in conjunction with variable skin plicated replacement surgery. A 30-year- reported a 5-year-old boy with severe, hyperextensibility, atrophic scarring and old male had a secundum-type atrial progressively deforming OI (OI type joint hypermobility, and autosomal septum defect (ASD), MVP with regur- III). No cardiac abnormalities were recessive inheritance. gitation, and aortic valve regurgitation. reported in this patient [Nicholls et al., He underwent mitral and aortic valve 1984]. A homozygous 4-nucleotide Muscoloskeletal system replacement with no complications. His frame shift deletion within the carboxy Three patients were reported to have 25-year-old brother had aortic valve (C)-terminal propeptide of pro-a2(I) GJH, whereas in the other three the replacement because of aortic insuffi- collagen was identified. This mutation hypermobility was restricted to the ciency [Schwarze et al., 2004]. 78 AMERICAN JOURNAL OF MEDICAL GENETICS PART C (SEMINARS IN MEDICAL GENETICS) RESEARCH REVIEW
The two reported children had no The History of EDS Arthrochalasia that lead to entire or partial loss of severe cardiovascular features, although Type exon 6 of either COL1A1 or mitral valve bulging was noted in one COL1A2 determines lack of the N- Hass and Hass [1958] proposed pres- [Nicholls et al., 2001; Malfait et al., telopeptide linking the N-propeptide ence of a distinct entity of congenital 2006]. to the major triple helical domain of flaccidity of the joints, which they the a1(I) or the a2(I) chain. Deletion called “arthrochalasis multiplex con- of the respective 24 and 18 amino acid genita” and which may or may not residues in the pro-a1(I) and the pro- Genotype–Phenotype Correlations involve skin changes. In 1973, three a2(I) chain results in loss of the small and Penetrance patients with the condition “EDS VII” globular region of the N-propeptide were reported with accumulation of All mutations result in complete absence (present only in the pro-a1(I) chain), procollagen in their skin and tendon of the proa2(I) chains. There are no the procollagen N-proteinase cleavage [Lichtenstein et al., 1973a]. The disor- reported genotype–phenotype correla- site (Pro-Gln and Ala-Gln at positions der was therefore supposed to be tions. Obligate carriers displayed no 4–5, respectively), the cross-linking caused by a defect in the conversion overt symptoms. Penetrance is presum- lysine residue at position 13 and 9, of procollagen to collagen, resembling ably complete. respectively, of the N-telopeptide dermatosparaxis in cattle, and the and the first triplet of the main helical activity of the converting proteinase Gly-X-Y domain [Giunta et al., Management in the cultured fibroblasts from these 1999]. patients was found to be reduced to Key management guidelines focus on between 10 and 40% of normal the cardiovascular system. [Lichtenstein et al., 1973b]. However, Allelic Heterogeneity Specific management guidelines Steinmann et al. [1980] demonstrated, include: Most of the mutations are splice site through reinvestigation of the fibro- mutations leading to skipping of exon 6 blasts from one of the patients, the – Measurement of aortic root size and in COL1A1 (intron 5 2A>G/T; in- presence of mutant pNa2(I) collagen assessment of heart valves by echocar- tron 5 1G>A/C/T; exon 6 1G>A/ chains (precursor procollagen chains diogram at the time of diagnosis or by C) or COL1A2 (intron 5 2A>G; in which the (C)- but not the age 5 years intron 5 1G>A/C; exon 6 1G>A; N-propeptide is cleaved off) in colla- – Yearly echocardiogram, even if the intron 6þ1G>A/T/C; intron gen extracted from skin or produced initial echocardiogram is normal 6þ2T>C/G) [Steinmann et al., 2002]. by fibroblasts and the normal activity – Cardiac valve replacement surgery Genomic deletions of exon 6 [Byers of procollagen N-proteinase in cell – Consider bone densitometry evaluation et al., 1997] and exon 5þ6 [Nicholls extracts. They concluded the condition et al., 2000] were also reported. to be caused by a structural abnormal- Management guidelines for mus- There is a registry of reported ity in the portion of the pro-a2(I) culoskeletal problems, skin, ophthal- COLI gene variants [Dalgleish, 1998]. chain that is normally cleaved by mologic and dental follow-up, and N-proteinase (and other proteinases) pregnancy should follow those formu- [Steinmann et al., 1980]. Subsequently, Clinical Description lated for other forms of EDS (for Cole et al. [1987] found mutant reference: See “management guide- At present, 49 patients from 36 pNa1(I) in a patient with similar lines for the classical Ehlers–Danlos families have been published (Table features. EDS VII was, therefore, syndrome,” by Bowen et al., this S1). The ages at the publication subdivided into types VIIA and issue). ranged from 2.5 months to 46 years type VIIB, depending on whether (n ¼ 35; Median age, 7.5 years of age) the a1(I) or the a2(I) chain is [Steinmann et al., 1980; Eyre et al., Differential Diagnosis affected, respectively [Beighton et al., 1985; Cole et al., 1986; Viljoen et al., 1998]. 1987; D’Alessio et al., 1991; Nicholls Prevalence of this condition is Classical EDS et al., 1991; Vasan et al., 1991; Chiodo unknown. Hypermobile EDS et al., 1992; Pope et al., 1992; Carr et al., 1994; Ho et al., 1994; Lehmann Mechanism of Disease et al., 1994; Byers et al., 1997; Giunta et al., 1999; Hudgins et al., 1999; ARTHROCHALASIA EDS Arthrochalasia EDS is caused by Nicholls et al., 2000; Whitaker et al., (aEDS) heterozygous mutations in either 2009; Giovannucci Uzielli et al., Synonyms: Ehlers–Danlos syndrome, COL1A1 (previously EDS type 2011; Klaassens et al., 2012; Giunta type VII (VIIA, VIIB); Arthrochalasis VIIA) or COL1A2 (previously EDS and Steinmann, 2014; Hatamochi multiplex congenita type VIIB). Heterozygous mutations et al., 2014]. RESEARCH REVIEW AMERICAN JOURNAL OF MEDICAL GENETICS PART C (SEMINARS IN MEDICAL GENETICS) 79
The hallmarks of the disorder are picture of the phenotype are given in a total of 11 children, including seven severe generalized joint hypermobility, Fig. 1). affected ones. Pregnancy or delivery- congenital bilateral hip dislocation, and related complications included breech recurrent subluxations and dislocations Reproductive, including pregnancy presentation (n ¼ 4), PPROM (n ¼ 2), of both small and large joint At least four affected women were polyhydramnios (n ¼ 2), and decreased [Steinmann et al., 2002] (Representative reported to be pregnant, and to deliver fetal movement (n ¼ 2).
Figure 1. Clinical photographs and radiological images of patients with aEDS. A girl (A–G) with a c.279þ1G> mutation in COL1A2 and a mother and her two sons (H–J) with a c.279þ2T>CinCOL1A2.(A) X-rays of the hip at age 7 days showing congenital bilateral hip dislocation and femoral and acetabular deformities. (B and C) Status of the hip dislocation at age 5 months and 3 years, respectively. (D) An anterioposterior total body radiograph at age 11 years showing unsuccessful treatment of the hip dislocation with harness and bracing. (E) A left lateral total body radiograph at age 11 years showing lumbar lordosis. (F and G) The patient at age 9 years with umbilical hernia, lordotic posture of the spine, and foot deformities. Foot deformities of an affected mother at age 38 years (H), her first son at age 14 years (I), and her second son at age 5 years (J) (Images A–G kindly provided by Prof. Maria Luisa Giovannucci-Uzielli, with permission). 80 AMERICAN JOURNAL OF MEDICAL GENETICS PART C (SEMINARS IN MEDICAL GENETICS) RESEARCH REVIEW